Previous 10 | Next 10 |
Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...
Artivion Inc Com (AORT) is expected to report $0.01 for Q3 2023
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results PR Newswire ATLANTA , Oct. 19, 2023 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, ann...
2023-10-13 14:37:09 ET Summary Artivion has used M&A to reposition itself towards growth opportunities in aortic disease care and heart valves. The company's legacy operations contribute positively to revenue and margins but have limited growth prospects. The success of Ar...
Artivion Announces Presentation of Real World Data from Post Market Study of On-X® Aortic Heart Valve Replacement Patients Treated with Low Dose Warfarin PR Newswire Late-Breaking Science Presented at the 37 th European Association for Cardio-Thoracic Surgery Annu...
Artivion Announces Presentation of Late-Breaking Interim Data from AMDS PERSEVERE Trial at the 37th European Association for Cardio-Thoracic Surgery Annual Meeting PR Newswire Interim Data Demonstrate Meaningful Reduction of All-Cause Mortality with AMDS ATLANTA ...
Artivion to Present at the Deutsche Bank 31st Annual Leveraged Finance Conference PR Newswire ATLANTA , Sept. 26, 2023 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will ...
2023-08-05 13:28:03 ET Artivion, Inc. (AORT) Q2 2023 Earnings Conference Call August 3, 2023 4:30 AM ET Company Participants Laine Morgan – Gilmartin Group Pat Mackin – Chief Executive Officer Ashley Lee – Chief Financial Officer Confer...
2023-08-03 16:46:39 ET Artivion press release ( NYSE: AORT ): Q2 Non-GAAP EPS of $0.06 beats by $0.04 . Revenue of $89.3M (+11.2% Y/Y) beats by $5.06M . Achieved EBITDA of $9.2 million in the second quarter of 2023; non-GAAP adjusted EBITDA increased 35% to $13...
Artivion Reports Second Quarter 2023 Financial Results PR Newswire Second Quarter and Recent Business Highlights: Achieved revenue of $89.3 million in the second quarter of 2023 versus $80.3 million in the second quarter of 2022, an increase of 11% on both a GA...
News, Short Squeeze, Breakout and More Instantly...
2024-07-02 12:00:05 ET Frank Takkinen from Loop Capital Markets issued a price target of $30.00 for AORT on 2024-07-02 08:49:00. The adjusted price target was set to $30.00. At the time of the announcement, AORT was trading at $26.015. The overall price target consensus ...
Artivion Amends Agreements with Endospan PR Newswire Provides Endospan with $25 million of Additional Debt Funding to Obtain FDA Approval for NEXUS Upfront Payment Associated with Purchase Option Reduced to $135 million , inclusive of loan off-set, and $100 m...
2024-06-19 19:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...